SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Meis-Kindblom JM, Kindblom LG. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet. Am J Surg Pathol. 1998; 22: 911-924.
  • 2
    Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001; 32: 704-14.
  • 3
    Montgomery EA, Devaney KO, Giordano TJ, Weiss SW. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Mod Pathol. 1998; 11: 384.
  • 4
    Oda Y, Tamiya S, Oshiro Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int. 2002; 52: 595-606.
  • 5
    Lang JE, Dodd L, Martinez S, Brigman BE. Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review. Clin Orthop Relat Res. 2006; 445: 254-60.
  • 6
    Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997; 15: 350-362.
  • 7
    Sakaki M, Hirokawa M, Wakatsuki S, et al. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature. Virchows Arch. 2003; 442: 25-30.
  • 8
    Ebhardt H, Kosmehl H, Katenkamp D. Acral myxoinflammatory fibroblastic sarcoma. Six cases of a tumor entity. Pathologe. 2001; 22: 157-161.
  • 9
    Jurcic V, Zidar A, Montiel MD, et al. Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites. Ann Diagn Pathol. 2002; 6: 272-280.
  • 10
    Kovarik CL, Barrett T, Auerbach A, Cassarino DS. Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis. J Cutan Pathol. 2008; 35: 192-196.
  • 11
    Kusumi T, Nishikawa S, Tanaka M, et al. Low-grade fibromyxoid sarcoma arising in the big toe. Pathol Int. 2005; 55: 802-806.
  • 12
    Lambert I, Debiec-Rychter M, Guelinckx P, Hagemeijer A, Sciot R. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes. Virchows Arch. 2001; 438: 509-512.
  • 13
    Yasuda T, Kanamori M, Nobukiyo M, Nogami S, Hori T, Kimura T. Acral myxoinflammatory fibroblastic sarcoma of the foot. J Exp Clin Cancer Res. 2007; 26: 277-280.
  • 14
    Hassanein AM, Atkinson SP, Al-Quran SZ, Jain SM, Reith JD. Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms? J Cutan Pathol. 2008; 35: 186-191.
  • 15
    Narvaez JA, Martinez S, Dodd LG, Brigman BE. Acral myxoinflammatory fibroblastic sarcomas: MRI findings in four cases. AJR Am J Roentgenol. 2007; 188: 1302-1305.
  • 16
    Baldini EH, Goldberg J, Jenner C, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 1999; 17: 3252-3259.
  • 17
    Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005; 75: 48-53.
  • 18
    Stinson SF, DeLaney TF, Greenberg J, et al. Acute and long term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1991; 21: 1493-1499.
  • 19
    Alektiar KM, Brennan MF, Healey JH, et al. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. J Clin Oncol. 2008; 26: 3440-3444.
  • 20
    Johnstone PA, Wexler LH, Venzon DJ, et al. Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation. Int J Radiat Oncol Biol Phys. 1994; 29: 735-745.
  • 21
    Okunieff P, Suit HD, Proppe KH. Extremity preservation by combined modality treatment of sarcomas of the hand and wrist. Int J Radiat Oncol Biol Phys. 1986; 12: 1923-1929.
  • 22
    Talbert ML, Zagars GK, Sherman NE, Romsdahl MM. Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot. Cancer. 1990; 66: 2482-2491.